 Nutriband Inc NASDAQ: NTRB is soaring Friday morning after the company announced the Korean Intellectual Property Office fully issued its patent titled Abuse and Misuse Deterrent Transdermal System which is related to the companys lead technology AVERSA. AVERSA is 4p Therapeutics abuse deterrent transdermal system, which uses taste aversion to address the primary routes of abuse for opioid based transdermal patches. 